{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:37:15Z","timestamp":1791463035185,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,10]]},"DOI":"10.7759\/cureus.23043","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T21:39:14Z","timestamp":1646948354000},"source":"Crossref","is-referenced-by-count":3,"title":["Use of Parathyroid Function Index and Wisconsin Index to Differentiate Primary Hyperparathyroidism From Secondary Hyperparathyroidism: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Murat Bulut","family":"\u00d6zkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veysel Bar\u0131\u015f","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197901000-00001","article-title":"Parathormone and perinatal calcium homeostasis","volume":"13","author":"Schedewie HK","year":"1979","unstructured":"Schedewie HK, Odell WD, Fisher DA, Krutzik SR, Dodge M, Cousins L, Fiser WP. Parathormone and perinatal calcium homeostasis. Pediatr Res. 1979, 13:1-6. 10.1203\/00006450-197901000-00001","journal-title":"Pediatr Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.10.007","article-title":"TNFalpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics","volume":"38","author":"Dai JC","year":"2006","unstructured":"Dai JC, He P, Chen X, Greenfield EM. TNFalpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics. Bone. 2006, 38:509-20. 10.1016\/j.bone.2005.10.007","journal-title":"Bone"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian JP","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018, 391:168-78. 10.1016\/S0140-6736(17)31430-7","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker MD","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018, 14:115-25. 10.1038\/nrendo.2017.104","journal-title":"Nat Rev Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler ML","year":"2015","unstructured":"Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015, 73:1-7. 10.1016\/j.bone.2014.12.003","journal-title":"Bone"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1762","article-title":"Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Khan A","year":"2009","unstructured":"Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009, 94:373-81. 10.1210\/jc.2008-1762","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01142-w","article-title":"Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry","volume":"39","author":"Arya AK","year":"2021","unstructured":"Arya AK, Kumari P, Bhadada SK, et al.. Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry. J Bone Miner Metab. 2021, 39:253-9. 10.1007\/s00774-020-01142-w","journal-title":"J Bone Miner Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101514","article-title":"Primary hyperparathyroidism","volume":"34","author":"Oberger Marques JV","year":"2020","unstructured":"Oberger Marques JV, Moreira CA. Primary hyperparathyroidism. Best Pract Res Clin Rheumatol. 2020, 34:101514. 10.1016\/j.berh.2020.101514","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick MF","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007, 357:266-81. 10.1056\/NEJMra070553","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.4.0437","article-title":"Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications","volume":"22","author":"Lips P","year":"2001","unstructured":"Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001, 22:477-501. 10.1210\/edrv.22.4.0437","journal-title":"Endocr Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90682-2","article-title":"Differences in vitamin D status between countries in young adults and the elderly","volume":"93","author":"McKenna MJ","year":"1992","unstructured":"McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992, 93:69-77. 10.1016\/0002-9343(92)90682-2","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050030","article-title":"Prevalence of vitamin D insufficiency in an adult normal population","volume":"7","author":"Chapuy MC","year":"1997","unstructured":"Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997, 7:439-43. 10.1007\/s001980050030","journal-title":"Osteoporos Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell R","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D'Amour P, Shoback DM, Thakker RV. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014, 99:3570-9. 10.1210\/jc.2014-1414","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian JP","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014, 99:3561-9. 10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0487-8","article-title":"New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study","volume":"20","author":"Guo Y","year":"2020","unstructured":"Guo Y, Wang Q, Lu C, Fan P, Li J, Luo X, Chen D. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study. BMC Endocr Disord. 2020, 20:5. 10.1186\/s12902-019-0487-8","journal-title":"BMC Endocr Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.33631\/duzcesbed.547378","article-title":"Hipokalsemi Olan Hastalarda Serum Kalsiyum D\u00fczeylerinin \u0130yonize ve D\u00fczeltilmi\u015f Kalsiyum ile \u0130li\u015fkisi","volume":"9","author":"Dogan \u00d6","year":"2019","unstructured":"Dogan \u00d6. Hipokalsemi Olan Hastalarda Serum Kalsiyum D\u00fczeylerinin \u0130yonize ve D\u00fczeltilmi\u015f Kalsiyum ile \u0130li\u015fkisi. D\u00fczce \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Enstit\u00fcs\u00fc Dergisi. 2019, 9:67-70. 10.33631\/duzcesbed.547378","journal-title":"D\u00fczce \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Enstit\u00fcs\u00fc Dergisi"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31825ffbe1","article-title":"Creation of a \"Wisconsin index\" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy","volume":"257","author":"Mazeh H","year":"2013","unstructured":"Mazeh H, Chen H, Leverson G, Sippel RS. Creation of a \"Wisconsin index\" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Ann Surg. 2013, 257:138-41. 10.1097\/SLA.0b013e31825ffbe1","journal-title":"Ann Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2040284","article-title":"Evaluation of Wisconsin and CaPTHUS indices usefulness for predicting monoglandular and multiglandular disease in patients with primary hyperparathyroidism through the analysis of a single-center experience","volume":"2021","author":"De Pasquale L","year":"2021","unstructured":"De Pasquale L, Lori E, Bulfamante AM, Felisati G, Castellani L, Saibene AM. Evaluation of Wisconsin and CaPTHUS indices usefulness for predicting monoglandular and multiglandular disease in patients with primary hyperparathyroidism through the analysis of a single-center experience. Int J Endocrinol. 2021, 2021:2040284. 10.1155\/2021\/2040284","journal-title":"Int J Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037%2Fgs-20-857","article-title":"Usefulness of the Wisconsin and CaPTHUS indices for predicting multiglandular disease in patients with primary hyperparathyroidism in a southern European population","volume":"10","author":"Serradilla-Mart\u00edn M","year":"2021","unstructured":"Serradilla-Mart\u00edn M, Palomares-Cano A, Cantalejo-D\u00edaz M, et al.. Usefulness of the Wisconsin and CaPTHUS indices for predicting multiglandular disease in patients with primary hyperparathyroidism in a southern European population. Gland Surg. 2021, 10:861-9. 10.21037%2Fgs-20-857","journal-title":"Gland Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01025-6","article-title":"Reliability of calcium-phosphorus (Ca\/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders","volume":"42","author":"Madeo B","year":"2019","unstructured":"Madeo B, De Vincentis S, Kara E, Vescini F, Trenti T, Guaraldi G, Rochira V. Reliability of calcium-phosphorus (Ca\/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders. J Endocrinol Invest. 2019, 42:1041-9. 10.1007\/s40618-019-01025-6","journal-title":"J Endocrinol Invest"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02276-7","article-title":"The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study","volume":"68","author":"Madeo B","year":"2020","unstructured":"Madeo B, De Vincentis S, Repaci A, et al.. The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study. Endocrine. 2020, 68:679-87. 10.1007\/s12020-020-02276-7","journal-title":"Endocrine"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10019","article-title":"Serum calcium to phosphorous (Ca\/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism","volume":"2","author":"Madeo B","year":"2018","unstructured":"Madeo B, Kara E, Cioni K, et al.. Serum calcium to phosphorous (Ca\/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism. JBMR Plus. 2018, 2:109-17. 10.1002\/jbm4.10019","journal-title":"JBMR Plus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers RA","year":"2006","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ 3rd. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006, 21:171-7. 10.1359\/JBMR.050910","journal-title":"J Bone Miner Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01633-1","article-title":"Total and free vitamin D metabolites in patients with primary hyperparathyroidism","volume":"45","author":"Meng L","year":"2022","unstructured":"Meng L, Su C, Shapses SA, Wang X. Total and free vitamin D metabolites in patients with primary hyperparathyroidism. J Endocrinol Invest. 2022, 45:301-7. 10.1007\/s40618-021-01633-1","journal-title":"J Endocrinol Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5223\/pghn.2019.22.3.233","article-title":"Association between vitamin D deficiency and suspected nonalcoholic fatty liver disease in an adolescent population","volume":"22","author":"Cho YH","year":"2019","unstructured":"Cho YH, Kim JW, Shim JO, Yang HR, Chang JY, Moon JS, Ko JS. Association between vitamin D deficiency and suspected nonalcoholic fatty liver disease in an adolescent population. Pediatr Gastroenterol Hepatol Nutr. 2019, 22:233-41. 10.5223\/pghn.2019.22.3.233","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-017-9424-1","article-title":"The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention","volume":"18","author":"Holick MF","year":"2017","unstructured":"Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017, 18:153-65. 10.1007\/s11154-017-9424-1","journal-title":"Rev Endocr Metab Disord"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2011.02383.x","article-title":"Vitamin D deficiency and prevention: Turkish experience","volume":"100","author":"Hatun \u015e","year":"2011","unstructured":"Hatun \u015e, Ozkan B, Bereket A. Vitamin D deficiency and prevention: Turkish experience. Acta Paediatr. 2011, 100:1195-9. 10.1111\/j.1651-2227.2011.02383.x","journal-title":"Acta Paediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89532-use-of-parathyroid-function-index-and-wisconsin-index-to-differentiate-primary-hyperparathyroidism-from-secondary-hyperparathyroidism-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:41Z","timestamp":1707507701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89532-use-of-parathyroid-function-index-and-wisconsin-index-to-differentiate-primary-hyperparathyroidism-from-secondary-hyperparathyroidism-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.23043","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}